Ideagen PLC Issue of new shares under the SIP and TVR (4601S)
March 16 2021 - 11:33AM
UK Regulatory
TIDMIDEA
RNS Number : 4601S
Ideagen PLC
16 March 2021
Ideagen PLC
("Ideagen," "the Company" or the "Group")
Issue of new shares under the Share Incentive Plan and Total
Voting Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information
Management Software to highly regulated industries, announces that
it has allotted a total of 3,305 new ordinary shares of 1 penny
each in the capital of the Company ("Ordinary Shares") following
the purchase of 3,305 Ordinary Shares by a number of employees
under the Company's Share Incentive Plan ("SIP").
Application has been made to the London Stock Exchange for the
3,305 new Ordinary Shares to be admitted to trading on AIM
("Admission") and it is expected that Admission will become
effective and trading will commence at 8.00 a.m. on 22 March
2021.
After Admission, the total number of Ordinary Shares in issue
will be 252,295,379 and the total number of voting rights will
therefore be 252,295,379. This figure may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under
the FCA's Disclosure and Transparency Rules.
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014.
Enquiries:
Ideagen plc 01629 699 100
David Hornsby, Executive Chairman
Ben Dorks, Chief Executive Officer
Emma Hayes, Chief Financial Officer
finnCap Limited 020 7220 0500
Henrik Persson/James Thompson
(Nomad)
Alice Lane (ECM)
Canaccord Genuity 020 7523 8000
Simon Bridges
Richard Andrews
About Ideagen plc
Ideagen is a UK-headquartered, global technology company quoted
on the London Stock Exchange AIM market (Ticker: IDEA.L).
A global supplier of regulatory and compliance solutions,
Ideagen provides a common software platform and an integrated
risk-based approach to meet multi-industry standards, enabling
compliance with relevant laws, policies, and regulations.
The Group provides software and services to organisations
operating within highly regulated industries such as life sciences,
healthcare, banking and finance, insurance, aviation, and aerospace
and defence, with its main operational premises spread throughout
the UK, EU, US, Middle East and SE Asia.
Currently, more than 5,700 organisations use Ideagen's products
including nine of the top 10 UK accounting firms, all of the top
aerospace and defence companies and 75% of the world's leading
pharmaceutical firms.
Ideagen's diverse and varied customer base includes many
well-known, global brands such as British Airways, Aggreko, BAE,
Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank,
Meggitt, Heineken, Johnson Matthey, Haeco Group and European
Central Bank. As well as this, Ideagen counts 250 hospitals across
the UK and US amongst its client base. For further information
please visit www.ideagen.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEDKABBPBKDCND
(END) Dow Jones Newswires
March 16, 2021 11:33 ET (15:33 GMT)
Ideagen (LSE:IDEA)
Historical Stock Chart
From Apr 2024 to May 2024
Ideagen (LSE:IDEA)
Historical Stock Chart
From May 2023 to May 2024